SRL
COGT icon

Scientech Research LLC’s Cogent Biosciences COGT Stock Holding History

Scientech Research LLC’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
+5,919
New +$219K 0.19% 204
2024
Q1 		– Sell
-11,649
Closed -$68.6K – 437
2023
Q4 		$68.6K Buy
+11,649
New +$89.3K 0.07% 277

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Scientech Research LLC's COGT Position: Q1 2026 in Review

Scientech Research LLC opened a new position in Cogent Biosciences (COGT) in Q1 2026: 5,919 shares worth $228K. The stake represents 0.19% of the portfolio and ranks #204 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in COGT as recently as Q4 2023.

Scientech Research LLC first reported a position in COGT in Q4 2023 and has held it in 2 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Scientech Research LLC held 5,919 shares of Cogent Biosciences worth $228K as of Q1 2026.
  • Cogent Biosciences was a new Scientech Research LLC position in Q1 2026.
  • Cogent Biosciences made up 0.19% of Scientech Research LLC's portfolio in Q1 2026, its #204 holding.
  • Scientech Research LLC first reported a position in Cogent Biosciences in Q4 2023 and has held it in 2 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.